1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Submission deadline September 25, 2027
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This NOFO supports the continued operation, maintenance, and dissemination of unique knowledge, data, and/or bioinformatics resources of major importance to the research community using animal models of embryonic developmental processes.
It also supports the ongoing development and enhancement of these resources, user training and services, provision of community-generated data storage and curation, wide dissemination of tools and/or resources, and expansion of interoperability with other NIH bioinformatics resources.
Get alerted about grants like this
Save a search for “Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The purpose of this Notice of Funding Opportunity (NOFO) is to support the continued operation, maintenance, and dissemination of unique knowledge, data, and/or bioinformatics resources that are of major importance to the research community using animal models of embryonic developmental processes.
These grants will support ongoing development and enhancement of the resources, user training and services, provision of community generated data storage and curation, wide dissemination of the tools and/or resources, and expansion of interoperability with other NIH bioinformatics resources.
</p> <p>The emergence and rapid evolution of high-resolution sequencing and other omics technologies have generated unprecedented quantities of molecular-level data from the analyses of biological systems. This rapid progress has been particularly significant in the areas of genomics and proteomics.
This exponential increase of information has been augmented by increased computing power to digitally record, store, and analyze large amounts of molecular data.
However, for the ever-increasing quantities of information to be maximally useful to biomedical scientists, it is necessary to establish and maintain resources that enable the compilation, annotation, storage, and dissemination of available data integrated with existing and/or contextualizing information in compliance with the FAIR Data principles (Findable, Accessible, Interoperable, and Reusable).
Additionally, corresponding tools in bioinformatics for data input, curation, and analysis, as well as technical support and user training are required to efficiently utilize these knowledge and/or data resources.
</p> <p>These Resource Program Grants in Bioinformatics are intended to support the continued availability, operation, improvement and maintenance of knowledge, data, digital information, bioinformatics tools and/or resources, user training and services, and wide dissemination of these tools or resources.
</p> <p>To qualify for support, knowledge or bioinformatics resources, such as software and algorithms, must be of demonstrable value toward advancing research utilizing animal model systems in the biomedical sciences and must also be of particular importance to those seeking to understand the biological basis of human and animal development and the etiology of structural congenital anomalies.
</p> <p>The resources must be sufficiently mature to have verifiable support from and utility for users within the developmental biology research community, operate according to FAIR data principles, and have a demonstrable national and international impact.
</p> <p>Examples of activities that Resource Program Grants in Bioinformatics are intended to support include but are not limited to:</p> <p>Resource Program Grants in Bioinformatics are not intended to support:</p> <p>Applicants who wish to undertake biomedical informatics research, to develop and test novel information technologies, or to perform feasibility or proof-of-concept studies, should respond to other NOFOs.
</p> <p>Applicants are strongly encouraged to consult with the Scientific/Research Contact listed below in Section VII to ensure that the proposed project reflects the objectives of this NOFO and the programmatic interests of the NICHD. </p> <p>See Section VIII. Other Information for award authorities and regulations.
</p>"/> Scout | PAR-24-301: NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) Summary This grant funds projects that focus on improving and expanding resources, training, and services in bioinformatics.
It aims to enhance data storage and curation provided by communities, increase the accessibility and use of tools and resources, and boost compatibility with other NIH bioinformatics resources.
The purpose of this Notice of Funding Opportunity (NOFO) is to support the continued operation, maintenance, and dissemination of unique knowledge, data, and/or bioinformatics resources that are of major importance to the research community using animal models of embryonic developmental processe… Load more Agency: <em>Eunice Kennedy Shriver</em> National Institute of Child Health and Human Development Sub-agency: National Institutes of Health Public Housing Authorities/Indian Housing Authorities Faith-based or Community-based Organizations Native American Tribal Organizations (other than Federally recognized tribal governments) Private Institutions of Higher Education Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations (Other than Small Businesses) Independent School Districts U.S. Territories or Possessions Foreign/Non-domestic entities are NOT eligible to apply.
Specifically, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed w… Opportunity Released: September 24, 2024 Open for Submission: September 24, 2024 Submission Deadline: September 25, 2027 Application Window Closes: September 25, 2027 National Institutes of Health Secure Grant Funding 10x Faster Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, Trusted by 500+ Happy Customers Get opportunities sent to your inbox The latest grant news and insights from our experts.
Share this opportunity with others. Anyone with this link can view the opportunity details.
Based on current listing details, eligibility includes: Not intended for research and development for proof of concept or initial tool development. Focus is on continued operation, maintenance, and enhancement of existing, critical bioinformatics resources. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Supports clinical trials that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes, focusing on fundamental aspects of phenomena without specific application towards processes or products in mind.
Novel Experiential Technologies Assisting Individual learning Hubs (NExT AI Hubs) is sponsored by National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This initiative seeks to advance NICHD's mission through a Centers program carrying out research on the impact of Artificial Intelligence (AI) technologies on developmental outcomes in children at risk for developing, or who have been diagnosed with, a specific learning disability (SLD) impacting reading, writing, and mathematics.
Novel Experiential Technologies Assisting Individual Learning Hubs (NExT AI Hubs) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - NIH. This initiative seeks to advance NICHD's mission through a Centers program that will carry out research on understudied, highly innovative, and high-risk research topics related to the impact of Artificial Intelligence (AI) technologies on developmental outcomes in children at r…
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.